CLINICAL_TRIALS ClinicalTrials.gov record update

A Post-marketing Study to Monitor the Safety of Beijing Tiantan Biological's Influenza Virus Vaccine Administered in Chinese Subjects Aged 60 Years or Older

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01906593
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:28.081402+00:00
Published At: 2013-07-24T00:00:00+00:00
Record Updated At: 2013-07-24
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Influenza", "Vaccination Adverse Event"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2013-07-24"
protocolSection.identificationModule.nctId: "NCT01906593"
protocolSection.identificationModule.officialTitle: "A Post-marketing Study to Monitor the Safety of Beijing Tiantan Biological\u0027s Influenza Virus Vaccine Administered in Chinese Subjects Aged 60 Years or Older"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.